University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia

Phase 4

Completed

Conditions: Frontal Lobe Dementia
Frontotemporal Lobe Dementia
Semantic Dementia

Interventions: Drug: memantine
Drug: Placebo pill

First Posted Date: 2007-10-18

Last Posted Date: 2020-11-17

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 81

Registration Number: NCT00545974

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
University Hospitals of Cleveland / Case Medical Center, Cleveland, Ohio, United States

and more 6 locations

Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2

Phase 1

Completed

Conditions: Breast Cancer
Metastatic Cancer

Interventions: Drug: lapatinib ditosylate
Genetic: gene expression analysis
Other: diagnostic laboratory biomarker analysis

First Posted Date: 2007-10-16

Last Posted Date: 2014-07-02

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 41

Registration Number: NCT00544804

Locations: 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

Evaluating Parental Influences on Obesity Among Mexican American Children

Completed

Conditions: Obesity

First Posted Date: 2007-10-11

Last Posted Date: 2013-05-22

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 831

Registration Number: NCT00542672

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

The Health in Pregnancy (HIP) Study

Not Applicable

Completed

Conditions: Pregnancy

First Posted Date: 2007-10-08

Last Posted Date: 2013-08-07

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 410

Registration Number: NCT00540319

Locations: 🇺🇸
UCSF Faculty Obstetrics and Gynecology Group, San Francisco, California, United States
🇺🇸
St. Luke's Hospital, San Francisco, California, United States
🇺🇸
Highland Hospital, Oakland, California, United States

and more 2 locations

Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery

Phase 2

Terminated

Conditions: Esophageal Cancer

Interventions: Drug: Erlotinib
Drug: 5-fluorouracil
Drug: Leucovorin
Drug: Oxaliplatin

First Posted Date: 2007-10-04

Last Posted Date: 2020-03-23

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 7

Registration Number: NCT00539617

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Interactions Between HIV and Malaria in African Children

Phase 3

Completed

Conditions: Malaria
HIV Infections

Interventions: Drug: Artemether-lumefantrine
Drug: Trimethoprim-sulfamethoxazole
Drug: Dihydroartemisinin-piperaquine

First Posted Date: 2007-09-11

Last Posted Date: 2013-10-11

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 351

Registration Number: NCT00527800

Locations: 🇺🇬
Tororo District Hospital, Tororo, Uganda

Valproic Acid (Depakote ER) in Patients With Advanced Thyroid Cancer

Phase 2

Terminated

Conditions: Head and Neck Cancer

Interventions: Drug: Valproic Acid

First Posted Date: 2007-09-05

Last Posted Date: 2015-02-03

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 5

Registration Number: NCT00525135

Locations: 🇺🇸
UCSF Comprehensive Cancer Center, San Francisco, California, United States

Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma

Phase 2

Completed

Conditions: Glioblastoma
Gliosarcoma

Interventions: Drug: Bevacizumab
Drug: Tarceva
Drug: Temozolomide

First Posted Date: 2007-09-05

Last Posted Date: 2014-11-14

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 74

Registration Number: NCT00525525

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Randomized Controlled Trial of Bipolar Versus Ultrasonic Hemostasis Techniques in Thyroidectomy

Not Applicable

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2007-09-05

Last Posted Date: 2011-07-11

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 100

Registration Number: NCT00524966

Locations: 🇺🇸
UCSF Comprehensive Cancer Center, San Francisco, California, United States

The Mental Activity and eXercise Trial for Seniors

Not Applicable

Completed

Conditions: Cognitive Impairment

Interventions: Behavioral: Group 1
Behavioral: Group 3
Behavioral: Group 2
Behavioral: Group 4

First Posted Date: 2007-08-30

Last Posted Date: 2012-04-09

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 126

Registration Number: NCT00522899

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
San Francisco Veterans Affairs Medical Center, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy